Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single- and multiple-dose study of JTV-261 in healthy Japanese adult men
jRCT2071240028Phase 1Completed
- Sponsor
- Japan Tobacco
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of JTV-261 (4 arms), sponsored by Japan Tobacco. Primary endpoints: Safety and Pharmacokinetics. Started Aug 2024; status: completed.
02
Drugs
JTV-261
Beyond the preview
Go deeper on jRCT2071240028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240028.